quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 26, 2026

AITX's RAD Unveils RADSight 2.0 as the Next Evolution of Its Video Management Platform

View original at finance.yahoo.com
AITX's RAD Unveils RADSight 2.0 as the Next Evolution of Its Video Management Platform Designed for NVIDIA Jetson Processors, Advanced Edge Based Analytics, Autonomous Engagement, and the Demands of Modern Security Operations Detroit, Michigan--(Newsfile Corp…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • RADSight 2.0 rollout is expected to begin in February across Gen 4 device lineup

    80% confidence
  • RAD expects to continue to attract new business as it converts existing sales opportunities into deployed clients generating recurring revenue stream

    80% confidence
  • RADSight 2.0 architecture is expected to reduce overall power consumption by more than half compared to prior configurations

    80% confidence
  • Each Fortune 500 client has the potential of making numerous reorders over time

    80% confidence
  • The security and guarding services industry is nearly $50 billion (US)

    80% confidence
  • This evolution strengthens AITX's ability to deliver intelligent, reliable security solutions as market demand for autonomous and software-driven protection continues to grow

    80% confidence
  • RAD solutions provide cost savings to businesses of between 35%-80% when compared to manned security guarding and monitoring

    80% confidence
  • RAD has a prospective sales pipeline of over 35 Fortune 500 companies and numerous other client opportunities

    80% confidence

Citado nestas reportagens da Via News

O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
AITX's RAD Unveils RADSight 2.0 as the Next Evolution of Its Video Management Platform — Source | Via News | pt.VIA.NEWS